Live and killed human immunodeficiency virus type-1 increases the intracellular growth of Leishmania donovani in monocyte-derived cells

Scandinavian Journal of Infectious Diseases

Volumn 30, Issue 1, 1998, Pages 29-34

  Wolday, Dawit ^a   Akuffo, Hannah ^b   Fessahaye, Ghimja ^a   Valantine, Antonio ^b   Britton, Sven ^c  

^a ADDIS ABABA UNIVERSITY   (Ethiopia)

^b KAROLINSKA INSTITUTE   (Sweden)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ANTIPROTOZOAL ACTIVITY; ARTICLE; CELL CULTURE; GROWTH CURVE; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LEISHMANIA DONOVANI; LEISHMANIASIS; LEUKEMIA CELL LINE; MACROPHAGE; MONOCYTE; MONOCYTIC LEUKEMIA; NONHUMAN; PARASITEMIA;

EID: 0031864404     PISSN: 00365548     EISSN: None     Source Type: Journal    
DOI: 10.1080/003655498750002268     Document Type: Article

References (34)

1. Chang KP, Dwyer DM. Multiplication of a human parasite (Leishmania donovani) in the phagolysosomes of hamster macrophages in vitro. Science 1976; 193: 678-80.
2. Pearson RD, Wheeler DA, Harrison LH, Kay HD. The immunobiology of leishmaniasis. Rev Infect Dis 1983; 5: 907- 27.
3. Badaro R, Jones TC, Carvalho EM, Sampaio D, Reed SG, Barral A. New perspective on a subclinical form of visceral leishmaniasis. J Infect Dis 1986; 154: 1003-11.
4. Sacks DL, Lal SL, Shrivanstava SN, Blackwell J, Neva FA. Analysis of T-cell responsiveness in Indian Kala-azar. J Immunol 1987; 138: 908-13.
5. Berhe N, Hailu A, Wolday D, Negese Y, Cenni P, Frommel D. Ethiopian visceral leishmaniasis patients co-infected with HIV. Trans Roy Soc Trop Med Hyg 1995; 89: 205-7.
6. Montalban C, Martinez-Fernandez R, Calleja JL, Garcia-Diaz JD, Rubio R, Dronda F, et al. Visceral leishmaniasis (kalaazar) as an opportunistic infection in patients infected with HIV in Spain. Rev Infect Dis 1989; 11: 655-60.
7. Peter BS, Fish D, Golden R, Evans DA, Bryceson AD, Pinching AJ. Visceral leishmaniasis in HIV infection and AIDS: Clinical features and response to therapy. Q J Med 1990; 77: 1101-11.
8. Smith PD, Ohura K, Masur H, Lane H, Fauci AS, Wahl SM. Monocyte functions in the AIDS. Defective chemotaxis. J Clin Invest 1984; 74: 2121-8.
9. Pinching A, Jeffries D, Donaghy M, Munday P, McManus T, Moshatael O, et al. Studies of cellular immunity in male homosexuals in London. Lancet 1983; 2: 130-6.
10. Roux-Lombard P, Alajem D, Balavoine JF, Chofflom M, Despont JP, Hirschel B, et al. Altered function of peripheral blood monocytes in homosexual males and intravenous drug users with persistent generalized lymphadenopathy. Eur J Clin Invest 1986; 16: 262-70.
11. Wolday D, Akuffo H, Britton S, Hathaway A, Sander B. HIV-1 inhibits Leishmania-induced cell proliferation but not production of interleukin-6 and tumour necrosis factor alpha. Scand J Immunol 1994; 39: 380-6.
12. Tsuchiya K, Yamabe M, Yamaguchi Y, Kobayashi Y, Konno T, Tada K. Establishment and characterisation of a human acute monocytoid leukaemia cell line (THP-1). Int J Cancer 1980; 26: 171-6.
13. Ogunkolade BW, Lasneret J, Manjour L. Production massive d'amastigotes par une lignee de cellules monoblastoides humaines. Ann Parasitol Hum Comp 1989; 63: 238-40.
14. Molina JM, Scadden DT, Byrn R, Dinarello CA, Groopman JE. Production of TNF-α and IL-1(by monocytie cells infected with HIV. J Clin Invest 1989; 84: 733-7.
15. Mohammed AM, Taye T, Akuffo H. Mechanism of resistance to Leishmania aethiopica. I. Interferon-gamma in combination with a cytokine (not tumour necrosis factor-alpha) is required but can not act alone in the inhibition of intracellular forms of L. aethiopica in THP-1 cells. Eur J Immunol 1992; 22: 2331-7.
16. Sypek JP, Wyler DJ. Anti-leishmanial defence in macrophages triggered by TNF expressed on CD4+ T-lymphocyte plasma membrane. J Exp Med 1991; 174: 755-89.
17. Akuffo HO, Britton SFF. Contribution of non-Leishmania-specific immunity to resistance to Leishmania infection in humans. Clin Exp Immunol 1992; 87: 58-64.
18. Murray HW, Squires KE, Miralles CD. Acquired resistance and granuloma formation in experimental visceral leishmaniasis. Differential T-cell and lymphokine roles in initial versus established immunity. J Immunol 1992; 148: 1858-63.
19. Bogdan C, Gessner A, Rollinghoff M. Cytokines in leishmaniasis: a complex network of stimulatory and inhibitory interactions. Immunobiology 1993; 189: 356-96.
20. Reiner SL, Locksley RM. Cytokines in the differentiation of TH1/Th2 CD4+ subsets in leishmaniasis. J Cell Biochem 1993; 53: 323-9.
21. Fauci AS. The human immunodeficiency virus; infectivity and mechanisms of pathogenesis. Science 1988; 239: 617-22.
22. Murrary HW, Rubin BY, Masur H, Roberts RB. Impaired production of lymphokines and immune (gamma) interferon in the AIDS. N Engl J Med 1984; 310: 883-93.
23. Albrecht H, Sobottka T, Emminger C, Jablonowski H, Just G, Stoehr A. Visceral Leishmaniasis emerging as an important opportunistic infection in HIV-infected persons living in areas non-endemic for L. donovani. Arch Pathol Lab Med 1996; 120: 189-98.
24. Kallemius G, Koivula T, Rydgard KJ, Hoffner SE, Valentine A, Asjo B, et al. Human immunodeficiency virus type 1 enhances intracellular growth of Mycobacterium avium in human macrophages. Infect Immun 1992; 60: 2453-8.
25. Chirmule N, Kalyanaraman VS, Oyaizu N, Pahwa S. Inhibitory influences of envelope glycoproteins of HIV-1 on normal immune responses. J AIDS 1988; 1: 425-30.
26. Oyaizu N, Chirmule N, Kalyanaraman VS. Human immunodeficiency virus lype-1 envelope glycoprotein gp 120 produces immune defects in CD4+ T lymphocyte by inhibiting interleukin 2 mRNA. Proc Natl Acad Sci USA 1990; 87: 2379-83.
27. Martinez P, de la Vega E, Laguna F, Soriano V, Puentc S, Moreno V, et al. Diagnosis of visceral leishmaniasis in HIV-infected individuals using peripheral blood smears. AIDS 1993; 7: 227-30.
28. Harper ME, Marselle LM, Gallo RC, Wong-Staal F. Detection of lymphocyte expressing human T-lymphotropic virus type-III in lymph nodes and peripheral blood from infected individuals by in situ hybridisation. Proc Natl Acad Sci USA 1986; 83: 772-6.
29. Schnittman SM, Psallidopoulos MC, Lane HC, Thompson L, Baseler M, Massari F, et al. The reservoir for HIV-1 in human peripheral blood is a T cell that maintains expression of CD4. Science 1980; 245: 305-8.
30. Poli G, Bressler P, Kinter A, Duh E, Timmer WC, Rabson A, et al. IL-6 induces HIV expression in infected monocyte cells alone or in synergy with TNF- by transcriptal and postranscriptal mechanisms. J Exp Med 1990; 172: 151-8.
31. Bernier R, Turco SJ, Oliver M, Tremblay M. Activation of HIV-1 in monocytoid cells by the protozoan parasite L. donovani. J Virol 1995; 69: 7282-5.
32. Reed SG, da Silva JS, Ho JL, Koehler JK, Russo DM, Pihl DL, Coombs RW. Cytokine activation of human macrophages infected with HIV-1 to inhibit intracellular protozoa. J AIDS 1992; 5: 666-75.
33. Bacellar O, Brodskyn C, Guerreiro M, Barrel-Netto M, Costa CH, Coffman R, et al. Interleukin-12 restores interferon-α production and cytotoxic responses in visceral leishmaniasis. J Infect Dis 1996; 173: 1515-8.
34. Badaro R, Johnson WD. The role of Interferon-α in the treatment of visceral and diffuse cutaneous leishmaniasis. J Infect Dis 1993; 176 Suppl: 13-27.